Phase II trial of oxaliplatin, pemetrexed, and bevacizumab in previously-treated advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Heist, R. S.
Fidias, P.
Huberman, M.
Temel, J.
Sequist, L.
Lynch, T. J.
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7700
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase II Study of Oxaliplatin, Pemetrexed, and Bevacizumab in Previously Treated Advanced Non-small Cell Lung Cancer
    Heist, Rebecca Suk
    Fidias, Panos
    Huberman, Mark
    Ardman, Blair
    Sequist, Lecia V.
    Temel, Jennifer S.
    Lynch, Thomas J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) : 1153 - 1158
  • [2] Phase II trial of bevacizumab plus pemetrexed and carboplatin in previously untreated advanced nonsquamous non-small cell lung cancer
    Dalsania, C. J.
    Hageboutros, A.
    Harris, E.
    Krieger, K.
    Vora, C.
    Stevenson, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] A phase II study of continuous daily sunitinib dosing in patients with previously-treated advanced non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio V.
    Novello, Silvia
    Brahamer, Julie R.
    Govindan, Ramaswamy
    Rosell, Rafael
    Belani, Chandra P.
    Atkins, James N.
    Tye, Lesley
    Chao, Richard
    Socinski, Mark A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S470 - S470
  • [4] A phase II trial of denileukin difititox- in previously treated, advanced non-small cell lung cancer (NSCLC).
    Lewis, MAG
    Shukla, R
    Kleykamp, B
    Jazieh, AR
    Hainsworth, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 689S - 689S
  • [5] A phase II trial of denileukin diftitox in patients with previously treated advanced non-small cell lung cancer (NSCLC).
    Lewis, MAG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 653S - 653S
  • [6] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
    Waples, J. M.
    Auerbach, M.
    Boccia, R.
    Wiggans, R. G.
    Steis, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer
    Komiya, Takefumi
    Memmott, Regan M.
    Blumenthal, Gideon M.
    Bernstein, Wendy
    Ballas, Marc S.
    De Chowdhury, Roopa
    Chun, Guinevere
    Peer, Cody J.
    Figg, William D.
    Liewehr, David J.
    Steinberg, Seth M.
    Giaccone, Giuseppe
    Szabo, Eva
    Kawabata, Shigeru
    Tsurutani, Junji
    Rajan, Arun
    Dennis, Phillip A.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (03) : 247 - +
  • [8] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [9] Efficacy and safety of sunitinib in a multicenter phase II trial of previously treated, advanced non-small cell lung cancer (NSCLC)
    Socinski, Mark A.
    Novello, Silvia
    Sanchez, Jose M.
    Brahmer, Julie
    Govindan, Ramaswamy
    Belani, Chandra P.
    Atkins, James N.
    Gillenwater, Heidi H.
    Palleres, C.
    Chao, Richard C.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 218 - 218
  • [10] A phase II trial of first-line bevacizumab in combination with pemetrexed and carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC)
    Skaff, Z. G.
    Hageboutros, A.
    Krieger, K.
    Coakley, S.
    Somer, R.
    Stevenson, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345